Document is current
Any future updates will be listed below
-
Authors
Potez, Marine
Roman Souza, Gabriel https://orcid.org/0000-0001-5498-2351
Spiess, Philippe E. https://orcid.org/0000-0002-5723-1972
Pilon-Thomas, Shari
Chahoud, Jad https://orcid.org/0000-0002-8435-0264
- License Information
-
More Information
Article History
Accepted: 19 August 2025
First Online: 26 September 2025
Competing interests
: J.C. declares consulting or advisory roles at AVEO, DAVA Pharmaceuticals, Pfizer, Exelixis, Eisai and Merck. P.E.S. declares honoraria at UptoDate. S.P.-T. is an inventor on intellectual property related to the proliferation and expansion of tumour-infiltrating lymphocytes (TILs) that Moffitt Cancer Center has licensed to Iovance Biotherapeutics. Moffitt has also licensed IP to Tuhura Biopharma. S.P.-T. is also listed as a co-inventor on a patent application with Provectus Biopharmaceuticals and participates in sponsored research agreements with Provectus Biopharmaceuticals, Celgene, Iovance Biotherapeutics, Intellia Therapeutics, Dyve Biosciences and Turnstone Biologics that are not related to this research. S.P.-T. has received consulting fees from Seagen, Morphogenesis and KSQ Therapeutics. The other authors declare no competing interests.
